BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 273885)

  • 21. Long-term survival in acute leukemia. Twenty-two adult patients surviving for over five years.
    Evensen SA; Stavem P
    Acta Med Scand; 1986; 219(1):79-83. PubMed ID: 3456695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
    Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The outcome of sibling and unrelated donor allogeneic stem cell transplantation in adult patients with acute myeloid leukemia in first remission who were initially refractory to first induction chemotherapy.
    Cook G; Clark RE; Crawley C; Mackinnon S; Russell N; Thomson K; Pearce RM; Towlson K; Marks DI
    Biol Blood Marrow Transplant; 2006 Mar; 12(3):293-300. PubMed ID: 16503498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Our experiences in the treatment of acute leukemias in children].
    Stojimirović E; Cvetković P
    Bilt Hematol Transfuz; 1976; 4(1-2):55-62. PubMed ID: 182115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of acute myeloid leukemia with a protocol combining intensive induction chemotherapy, early consolidation treatment, splenectomy and long-term maintenance chemotherapy. Preliminary study].
    Machover D; Schwarzenberg L; D'Hubert E; Lemaigre G; Caillou B; Tourani JM; Michalski B; Goldschmidt E; Gaget H; De Vassal F; Misset JL; Dorval T; Ribaud P; Jasmin C; Hayat M; Rappaport H; Mathé G
    Nouv Presse Med; 1982 Dec; 11(52):3835-9. PubMed ID: 6819542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of acute myeloid leukemia in the elderly with low-dose cytosine arabinoside].
    Pedersen G; Stentoft J; Pedersen JO; Jensen MK
    Ugeskr Laeger; 1994 Oct; 156(43):6380-4. PubMed ID: 7810014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of patients who undergo aggressive induction therapy for secondary acute myeloid leukemia.
    Rizzieri DA; O'Brien JA; Broadwater G; Decastro CM; Dev P; Diehl L; Beaven A; Lagoo A; Gockerman JP; Chao NJ; Moore JO
    Cancer; 2009 Jul; 115(13):2922-9. PubMed ID: 19452542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group.
    Büchner T; Hiddemann W; Berdel WE; Wörmann B; Schoch C; Fonatsch C; Löffler H; Haferlach T; Ludwig WD; Maschmeyer G; Staib P; Aul C; Gruneisen A; Lengfelder E; Frickhofen N; Kern W; Serve HL; Mesters RM; Sauerland MC; Heinecke A;
    J Clin Oncol; 2003 Dec; 21(24):4496-504. PubMed ID: 14673036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemia.
    Malfuson JV; Etienne A; Turlure P; de Revel T; Thomas X; Contentin N; Terré C; Rigaudeau S; Bordessoule D; Vey N; Gardin C; Dombret H;
    Haematologica; 2008 Dec; 93(12):1806-13. PubMed ID: 18838471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic factors of acute non lymphoblastic leukemia in children and adults. Results from two multicentric trials (705 patients).
    Castaigne S; Chevret S; Lepage E; Guilhot F; Fenaux P; Bordessoule D; Tilly H; Auzanneau G; Tertian G; Guy H
    Nouv Rev Fr Hematol (1978); 1990; 32(5):297-300. PubMed ID: 2099400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [High dose combination chemotherapy with and without autologous bone marrow transplantation in patients with solid tumors and acute leukemias. Kinetics of recovery of peripheral bloods cells (author's transl)].
    Gorin NC; Najman A; David R; Stachowiak J; Hirsch Marie F; Muller JY; Petit JC; Leblanc G; Parlier Y; Jullien AM; Cavalier J; Salmon C; Duhamel G
    Nouv Presse Med; 1978 Dec; 7(45):4105-10. PubMed ID: 370764
    [No Abstract]   [Full Text] [Related]  

  • 32. [Acute myelogenous leukaemia: prognostic value of infectious complications observed during the induction treatment (author's transl)].
    Reiffers J; Vezon G; Broustet A
    Sem Hop; 1981 Jan 18-25; 57(3-4):133-7. PubMed ID: 6261351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapy of acute leukemia in adults].
    Lechner K
    Wien Med Wochenschr; 1991; 141(9-10):180-90. PubMed ID: 1949839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prognostic significance of age and karyotype in the treatment of acute myeloid leukemia: results at our center].
    Nahajevszky S; Kapás B; Adám E; Lovas N; Halm G; Gopcsa L; Tamáska J; Poros A
    Orv Hetil; 2004 Jan; 145(4):167-72. PubMed ID: 14978882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intensive timed chemotherapy protocol for 37 resistant or relapsing acute myeloid leukemias.
    Fière D; Campos L; Van HV; Guyotat D; Archimbaud E; Extra JM; Coiffier B; Viala JJ; Bryon PA; Milan JJ
    Cancer Treat Rep; 1986 Feb; 70(2):285-6. PubMed ID: 3456272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [On the consolidation, maintenance and reconsolidation treatment of acute leukemia (author's transl)].
    Masaoka T
    Nihon Ketsueki Gakkai Zasshi; 1974 Oct; 37(5):748-55. PubMed ID: 4533929
    [No Abstract]   [Full Text] [Related]  

  • 37. [Reinduction chemotherapy of acute leukemia with neocarzinostatin and other conventional antileukemic agents (author's transl)].
    Nagao T; Kammura O; Nozaki H; Takahashi Y; Niiya K
    Rinsho Ketsueki; 1976 Aug; 17(8):838-43. PubMed ID: 144198
    [No Abstract]   [Full Text] [Related]  

  • 38. High rate of long-term survival in adult acute leukemia following ten-day chemotherapy (OAP) induction. Maintenance with chemotherapy or chemotherapy plus BCG vaccine.
    Hewlett JS; Chen T; Balcerzak SP; Gutterman JU; Costanzi JJ; Amare M
    Arch Intern Med; 1985 Jun; 145(6):1006-12. PubMed ID: 3890786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [How to be an administration schedule of antileukemic agents in the treatment of acute leukemia from the standpoint of leukemic cell kinetics (author's transl)].
    Shirakawa S
    Nihon Ketsueki Gakkai Zasshi; 1974 Oct; 37(5):707-30. PubMed ID: 4533927
    [No Abstract]   [Full Text] [Related]  

  • 40. Remission of acute myelogenous leukemia complicating Waldenström macroglobulinemia.
    Effron MK; Rosenbaum J; Greenberg PL
    West J Med; 1978 Oct; 129(4):337-9. PubMed ID: 102080
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.